Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

642.30INR
6:25am EDT
Change (% chg)

Rs-3.85 (-0.60%)
Prev Close
Rs646.15
Open
Rs649.50
Day's High
Rs655.75
Day's Low
Rs640.00
Volume
321,970
Avg. Vol
524,928
52-wk High
Rs678.80
52-wk Low
Rs434.80

Latest Key Developments (Source: Significant Developments)

Sun Pharma Says Almirall Gets European Commission Approval For Ilumetri
7:23am EDT 

Sept 18 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMACEUTICAL INDUSTRIES LTD - ALMIRALL GETS EUROPEAN COMMISSION APPROVAL FOR ILUMETRI.  Full Article

Sun Pharmaceutical Industries Says USFDA Conducting Inspection Of Mohali Facilty
Tuesday, 11 Sep 2018 10:15am EDT 

Sept 11 (Reuters) - Sun Pharmaceutical Industries Ltd ::CLARIFIES ON NEWS ITEM, "SUN PHARMA'S MOHALI PLANT ON FDA RADAR".SUN PHARMACEUTICAL INDUSTRIES LTD <<>> - US FDA IS CONDUCTING AN INSPECTION OF SUN PHARMACEUTICAL INDUSTRIES'S MOHALI FACILITY .SUN PHARMACEUTICAL INDUSTRIES LTD <<>> - INSPECTION STARTED ON SEPTEMBER 10 AND IS ONGOING.  Full Article

Sun Pharmaceutical Industries Declares Interim Preference Dividend
Monday, 13 Aug 2018 09:30am EDT 

Aug 13 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS DECLARES INTERIM PREFERENCE DIVIDEND OF 10 RUPEES/PREFERENCE SHARE.  Full Article

India's Sun Pharma Industries March Qtr Consol Profit About 7 Pct
Friday, 25 May 2018 06:17am EDT 

May 25 (Reuters) - Sun Pharmaceutical Industries Ltd ::MARCH QUARTER CONSOL NET PROFIT 13.09 BILLION RUPEES VERSUS PROFIT OF 12.24 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR MARCH QUARTER CONSOL PROFIT WAS 9.47 BILLION RUPEES.MARCH QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 69.77 BILLION RUPEES VERSUS 71.37 BILLION RUPEES LAST YEAR.RECOMMENDED DIVIDEND OF 2 RUPEES PER SHARE.SUN PHARMACEUTICAL INDUSTRIES LTD - APPROVED COMPOSITE SCHEME OF ARRANGEMENT AMONG CO, SUN PHARMA (NETHERLANDS) B.V., SUN PHARMACEUTICAL HOLDINGS USA.  Full Article

Beijing Science Sun Pharmaceutical sees FY 2018 Q1 net profit up 10 pct to 40 pct
Monday, 2 Apr 2018 01:31am EDT 

April 2 (Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>:Says it sees FY 2018 Q1 net profit to increase by 10 percent to 40 percent, or to be 49.8 million yuan to 63.4 million yuan.Says FY 2017 Q1 net profit was 45.3 million yuan .  Full Article

Sun Pharmaceutical Industries Gets U.S. FDA Nod Of ILUMYA (Tildrakizumab-Asmn)
Wednesday, 21 Mar 2018 08:29am EDT 

March 21 (Reuters) - Sun Pharmaceutical Industries Ltd ::CO GETS U.S. FDA APPROVAL OF ILUMYA (TILDRAKIZUMAB-ASMN) FOR TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS.  Full Article

Sun Pharmaceutical Industries Says U.S. FDA Issued Form 483 With 3 Observations For Halol Facility
Friday, 23 Feb 2018 03:57am EST 

Feb 23 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMACEUTICAL INDUSTRIES -U.S. FDA CONDUCTED GMP INSPECTION OF HALOL FACILITY (GUJARAT, INDIA) FROM FEBRUARY 12-23, 2018.AT CONCLUSION OF INSPECTION, AGENCY ISSUED A FORM 483, WITH THREE OBSERVATIONS.SUN PHARMACEUTICAL INDUSTRIES - CO PREPARING RESPONSE TO FDA OBSERVATIONS, TO BE SUBMITTED WITHIN 15 BUSINESS DAYS.  Full Article

Sun Pharma Industries Says Qtrly US Finished Dosage Sales Down 35 Pct
Wednesday, 14 Feb 2018 06:04am EST 

Feb 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS US FINISHED DOSAGE SALES DURING QUARTER AT US$ 328 MILLION, DOWN 35 PERCENT OVER Q3 LAST YEAR.  Full Article

India's Sun Pharmaceutical Industries Dec-Qtr Consol Profit Down 75 Pct
Wednesday, 14 Feb 2018 05:26am EST 

Feb 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::DEC QUARTER CONSOL NET PROFIT AFTER TAX 3.65 BILLION RUPEES VERSUS PROFIT OF 14.72 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 9.12 BILLION RUPEES.DEC QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 66.54 BILLION RUPEES VERSUS 79.25 BILLION RUPEES LAST YEAR.SAYS CONSOL EXCEPTIONAL TAX EXPENSE IN QUARTER 5.13 BILLION RUPEES.  Full Article

Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S.
Tuesday, 16 Jan 2018 08:38am EST 

Jan 16 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS CO'S UNITS HAVE REACHED AN AGREEMENT WITH IRONWOOD PHARMACEUTICALS, INC. AND ALLERGAN PLC.ANNOUNCES SETTLEMENT OF PATENT LITIGATION FOR GENERIC LINZES IN US.COMPANIES TO GRANT CO'S UNITS LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S FROM FEB 1, 2031 OR EARLIER UNDER CIRCUMSTANCES.ADDITIONAL DETAILS REGARDING THE SETTLEMENT WERE NOT DISCLOSED..  Full Article

Morning News Call - India, August 16

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_08162018.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 11:30 am: Banking Secretary Rajiv Kumar at launch of Canara Bank’s digital branch in New Delhi. LIVECHAT - BONDS UPDATE Reuters interest rate reporter Dhara Ranasinghe delves into gove